Isabel Aranguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isabel Aranguez has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Maria Soledad FernánDez-Alfonso
Instituto Pluridisciplinar and Faculty of Pharmacy Universidad Complutense de Madrid Madrid Spain
16 shared publications - Marta Gil-Ortega
Universidad San Pablo CEU
9 shared publications - Mariano Ruiz-Gayo
Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, Madrid, Spain
8 shared publications - Gema Ruiz-Hurtado
Cardiorenal Translational Laboratory, Imas12 Research Institute Hospital Universitario 12 de Octubre Madrid Spain
6 shared publications - Maria Carmen González
Department of Physiology, Faculty of Medicine, Universidad Autónoma de Madrid, c/Arzobispo Morcillo 2, 28029 Madrid, Spain
6 shared publications Beatriz Somoza
Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad CEU-San Plablo, Madrid, Spain
5 shared publications
Latest Publications
- Open Access
- 24 April 2026
- Published by Wiley in Acta Physiologica
- Vol. 242 (5)
Citrate‐Dependent Activation of Acetyl CoA Carboxylase Promotes Renal Lipid Accumulation in a Rat Model of Chronic Kidney Disease
Background: Abnormal accumulation of lipids within the kidney contributes to the progression of chronic kidney disease, but the underlying metabolic mechanisms remain unclear. Citrate is a central metabolite in cellular energy regulation and is frequently elevated in advanced kidney disease, yet its impact on renal lipid metabolism has not been investigated. This study tested whether increased circulating citrate promotes lipid accumulation in the kidney by activating acetyl‐CoA carboxylase independently of adenosine monophosphate‐activated protein kinase. Methods: Male Munich Wistar Frömter rats, a genetic model of chronic kidney disease, were studied together with HEK293 cells exposed to citrate. Protein expression, phosphorylation, and polymerization were assessed using western blotting, q‐RT‐PCR, and native gel electrophoresis. Renal lipid composition was characterized by untargeted high‐performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry, and citrate levels were semi‐quantified using capillary electrophoresis–time‐of‐flight mass spectrometry. Results: MWF rats exhibited elevated plasma citrate, reduced vitamin D and bone mineral density, and increased renal fibrosis and mitochondrial dysfunction. Moreover, MWF showed higher expression of ATP‐citrate lyase and fatty acid synthase, together with reduced phosphorylation of acetyl‐CoA carboxylase and AMP‐activated protein kinase, increased renal lipid deposition, and elevated fatty acid content. In HEK293, citrate treatment reproduced these effects, inducing acetyl‐CoA carboxylase polymerization, lipid droplet formation, impaired mitochondrial activity, and increased superoxide production. Conclusion: This study identifies citrate‐dependent activation of acetyl‐CoA carboxylase as a driver of renal lipid accumulation and remodeling independently of AMP‐activated protein kinase, revealing a novel metabolic mechanism linking systemic citrate to kidney injury and potential therapeutic strategies.
- 24 April 2026
- Published by Wiley in Acta Physiologica
- Vol. 242 (5)
Open AccessCitrate‐Dependent Activation of Acetyl CoA Carboxylase Promotes Renal Lipid Accumulation in a Rat Model of Chronic Kidney Disease
Background: Abnormal accumulation of lipids within the kidney contributes to the progression of chronic kidney disease, but the underlying metabolic mechanisms remain unclear. Citrate is a central metabolite in cellular energy regulation and is frequently elevated in advanced kidney disease, yet its impact on renal lipid metabolism has not been investigated. This study tested whether increased circulating citrate promotes lipid accumulation in the kidney by activating acetyl‐CoA carboxylase independently of adenosine monophosphate‐activated protein kinase. Methods: Male Munich Wistar Frömter rats, a genetic model of chronic kidney disease, were studied together with HEK293 cells exposed to citrate. Protein expression, phosphorylation, and polymerization were assessed using western blotting, q‐RT‐PCR, and native gel electrophoresis. Renal lipid composition was characterized by untargeted high‐performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry, and citrate levels were semi‐quantified using capillary electrophoresis–time‐of‐flight mass spectrometry. Results: MWF rats exhibited elevated plasma citrate, reduced vitamin D and bone mineral density, and increased renal fibrosis and mitochondrial dysfunction. Moreover, MWF showed higher expression of ATP‐citrate lyase and fatty acid synthase, together with reduced phosphorylation of acetyl‐CoA carboxylase and AMP‐activated protein kinase, increased renal lipid deposition, and elevated fatty acid content. In HEK293, citrate treatment reproduced these effects, inducing acetyl‐CoA carboxylase polymerization, lipid droplet formation, impaired mitochondrial activity, and increased superoxide production. Conclusion: This study identifies citrate‐dependent activation of acetyl‐CoA carboxylase as a driver of renal lipid accumulation and remodeling independently of AMP‐activated protein kinase, revealing a novel metabolic mechanism linking systemic citrate to kidney injury and potential therapeutic strategies.
- 2 March 2017
- Published by Wiley in British Journal of Pharmacology
- Vol. 174 (20) , 3561-3572
Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?
Perivascular adipose tissue (PVAT) releases numerous factors and adipokines with paracrine effects on both vascular structure and function. These effects are variable as they depend on regional differences in PVAT among blood vessels and vary with changes in adiposity. There is considerable evidence demonstrating an association between coronary PVAT and the development and progression of coronary artery disease, which is associated with inflammation, oxidative stress, angiogenesis, vascular remodelling and blood clotting. However, PVAT also has a protective role in vascular grafts, especially the no‐touch saphenous vein, in patients undergoing coronary artery bypass. This beneficial influence of PVAT involves factors such as adipocyte‐derived relaxing factor, nitric oxide (NO), leptin, adiponectin, prostanoids, hydrogen sulphide and neurotransmitters, as well as mechanical protection. This article aims to highlight and compare the dual role of PVAT in the development and progression of coronary atherosclerosis, as well as in increased graft patency. Different deleterious and protective mechanisms of PVAT are also discussed and the inside‐outside signalling paradigm of atherosclerosis development re‐evaluated. The bidirectional communication between the arterial and venous wall and their surrounding PVAT, where signals originating from the vascular wall or lumen can affect PVAT phenotype, has been shown to be very complex. Moreover, signals from PVAT also influence the structure and function of the vascular wall in a paracrine manner.Linked Articles: This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue – Potential Pharmacological Targets? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc
- 2 March 2017
- Published by Wiley in British Journal of Pharmacology
- Vol. 174 (20) , 3561-3572
Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?
Perivascular adipose tissue (PVAT) releases numerous factors and adipokines with paracrine effects on both vascular structure and function. These effects are variable as they depend on regional differences in PVAT among blood vessels and vary with changes in adiposity. There is considerable evidence demonstrating an association between coronary PVAT and the development and progression of coronary artery disease, which is associated with inflammation, oxidative stress, angiogenesis, vascular remodelling and blood clotting. However, PVAT also has a protective role in vascular grafts, especially the no‐touch saphenous vein, in patients undergoing coronary artery bypass. This beneficial influence of PVAT involves factors such as adipocyte‐derived relaxing factor, nitric oxide (NO), leptin, adiponectin, prostanoids, hydrogen sulphide and neurotransmitters, as well as mechanical protection. This article aims to highlight and compare the dual role of PVAT in the development and progression of coronary atherosclerosis, as well as in increased graft patency. Different deleterious and protective mechanisms of PVAT are also discussed and the inside‐outside signalling paradigm of atherosclerosis development re‐evaluated. The bidirectional communication between the arterial and venous wall and their surrounding PVAT, where signals originating from the vascular wall or lumen can affect PVAT phenotype, has been shown to be very complex. Moreover, signals from PVAT also influence the structure and function of the vascular wall in a paracrine manner.Linked Articles: This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue – Potential Pharmacological Targets? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc
- 17 February 2016
- Published by Portland Press Ltd. in Clinical Science
- Vol. 130 (7) , 525-538
Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria
Resistant albuminuria developed under adequate chronic renin-angiotensin system (RAS) blockade is a clinical problem present in a fraction of patients with chronic kidney disease (CKD). The mechanism underlying this resistant albuminuria remain unknown. Matrix metalloproteinases (MMPs) are involved in the pathophysiology of cardiovascular and renal disease. Here we tested the role of MMPs in resistant albuminuria. We first evaluated gelatinase MMP-2 and MMP-9 activity by zymography in the Munich Wistar Frömter (MWF) rat, a model of progressive albuminuria, and subsequently in patients with resistant albuminuria. Markers of oxidative stress were observed in kidneys of MWF rats together with a significant increase in proMMP-2 and active MMP-9 forms. These changes were normalized together with reduced albuminuria in consomic MWF-8SHR rats, in which chromosome 8 of MWF was replaced with the respective chromosome from spontaneous hypertensive rats (SHR). MMP-2 and MMP-9 protein levels were similar in patients with normal and resistant albuminuria; however, high circulating levels of collagen IV, a specific biomarker of tissue collagen IV degradation, were observed in patients with resistant albuminuria. These patients showed a significant increase in gelatinase MMP-2 and MMP-9 activity, but only a significant increase in the active MMP-9 form quantified by ELISA, which significantly correlated with albuminuria degree. Although TIMP-1 expression was similar, a novel AlphaLISA® assay demonstrated that MMP-9/TIMP-1 interaction was reduced in patients with resistant albuminuria. Interestingly, oxidized TIMP-1 (OxyTIMP-1) expression was higher in resistant albuminuric patients. Therefore, increased circulating MMP-9 activity associates with resistant albuminuria and a deleterious oxidative stress environment appears to be the underlying mechanism. These changes might contribute to the progression of CKD in these patients.
- 17 February 2016
- Published by Portland Press Ltd. in Clinical Science
- Vol. 130 (7) , 525-538
Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria
Resistant albuminuria developed under adequate chronic renin-angiotensin system (RAS) blockade is a clinical problem present in a fraction of patients with chronic kidney disease (CKD). The mechanism underlying this resistant albuminuria remain unknown. Matrix metalloproteinases (MMPs) are involved in the pathophysiology of cardiovascular and renal disease. Here we tested the role of MMPs in resistant albuminuria. We first evaluated gelatinase MMP-2 and MMP-9 activity by zymography in the Munich Wistar Frömter (MWF) rat, a model of progressive albuminuria, and subsequently in patients with resistant albuminuria. Markers of oxidative stress were observed in kidneys of MWF rats together with a significant increase in proMMP-2 and active MMP-9 forms. These changes were normalized together with reduced albuminuria in consomic MWF-8SHR rats, in which chromosome 8 of MWF was replaced with the respective chromosome from spontaneous hypertensive rats (SHR). MMP-2 and MMP-9 protein levels were similar in patients with normal and resistant albuminuria; however, high circulating levels of collagen IV, a specific biomarker of tissue collagen IV degradation, were observed in patients with resistant albuminuria. These patients showed a significant increase in gelatinase MMP-2 and MMP-9 activity, but only a significant increase in the active MMP-9 form quantified by ELISA, which significantly correlated with albuminuria degree. Although TIMP-1 expression was similar, a novel AlphaLISA® assay demonstrated that MMP-9/TIMP-1 interaction was reduced in patients with resistant albuminuria. Interestingly, oxidized TIMP-1 (OxyTIMP-1) expression was higher in resistant albuminuric patients. Therefore, increased circulating MMP-9 activity associates with resistant albuminuria and a deleterious oxidative stress environment appears to be the underlying mechanism. These changes might contribute to the progression of CKD in these patients.
- 1 February 2016
- Published by Elsevier in Vascular Pharmacology
- Vol. 77, 38-47
Arterial stiffness is associated with adipokine dysregulation in non-hypertensive obese mice
- 1 February 2016
- Published by Elsevier in Vascular Pharmacology
- Vol. 77, 38-47
Arterial stiffness is associated with adipokine dysregulation in non-hypertensive obese mice
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e115-e116
8D.08
- 1 June 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (Supplement) , e115-e116
8D.08
- 1 April 2015
- Published by Elsevier in Vascular Pharmacology
- Vol. 67-69, 10-20
Vascular AMPK as an attractive target in the treatment of vascular complications of obesity
- 1 April 2015
- Published by Elsevier in Vascular Pharmacology
- Vol. 67-69, 10-20
Vascular AMPK as an attractive target in the treatment of vascular complications of obesity
- 1 February 2015
- Published by Elsevier in Vascular Pharmacology
- Vol. 65-66, 3-12
Mild caloric restriction reduces blood pressure and activates endothelial AMPK-PI3K-Akt-eNOS pathway in obese Zucker rats
- 1 February 2015
- Published by Elsevier in Vascular Pharmacology
- Vol. 65-66, 3-12
Mild caloric restriction reduces blood pressure and activates endothelial AMPK-PI3K-Akt-eNOS pathway in obese Zucker rats
- 25 November 2014
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 59 (3) , 520-532
High-fat diet induces endothelial dysfunction through a down-regulation of the endothelial AMPK-PI3K-Akt-eNOS pathway
Scope Activation of endothelial adenosine monophosphate‐activated protein kinase (AMPK) contributes to increase nitric oxide (NO) availability. The aim of this study was to assess if high‐fat diet (HFD)‐induced endothelial dysfunction is linked to AMPK deregulation. Methods and results Twelve‐week‐old Sprague Dawley male rats were assigned either to control (10 kcal % from fat) or to HFD (45 kcal % from fat) for 8 wk. HFD rats segregated in obesity‐prone (OP) or obesity‐resistant (OR) rats according to body weight. HFD triggered an impaired glucose management together with impaired endothelium‐dependent relaxation, reduced endothelial AMPK activity and lower NO availability in aortic rings of OP and OR cohorts. Relaxation evoked by AMPK activator, 5‐aminoimidazole‐4‐carboxamide‐1‐β‐d‐ribofuranoside (AICAR) was reduced in both OP and OR rings, which exhibited lower p‐AMPKα‐Thr172/AMPKα ratios that negatively correlated with plasma non‐esterified fatty acids (NEFA) and triglycerides (TG). Inhibition of PI3K (wortmannin, 10−7 M) or Akt (triciribine, 10−5 M) reduced relaxation to AICAR only in the control group (p < 0.001). Akt (p‐Akt‐Ser473) and eNOS phosphorylation (p‐eNOS‐Ser1177) were significantly reduced in OP and OR (p < 0.01). Conclusion Endothelial dysfunction caused by HFD is related to a dysfunctional endothelial AMPK–PI3K–Akt–eNOS pathway correlating with the increase of plasma NEFA, TG, and an impaired glucose management.
- 25 November 2014
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 59 (3) , 520-532
High-fat diet induces endothelial dysfunction through a down-regulation of the endothelial AMPK-PI3K-Akt-eNOS pathway
Scope Activation of endothelial adenosine monophosphate‐activated protein kinase (AMPK) contributes to increase nitric oxide (NO) availability. The aim of this study was to assess if high‐fat diet (HFD)‐induced endothelial dysfunction is linked to AMPK deregulation. Methods and results Twelve‐week‐old Sprague Dawley male rats were assigned either to control (10 kcal % from fat) or to HFD (45 kcal % from fat) for 8 wk. HFD rats segregated in obesity‐prone (OP) or obesity‐resistant (OR) rats according to body weight. HFD triggered an impaired glucose management together with impaired endothelium‐dependent relaxation, reduced endothelial AMPK activity and lower NO availability in aortic rings of OP and OR cohorts. Relaxation evoked by AMPK activator, 5‐aminoimidazole‐4‐carboxamide‐1‐β‐d‐ribofuranoside (AICAR) was reduced in both OP and OR rings, which exhibited lower p‐AMPKα‐Thr172/AMPKα ratios that negatively correlated with plasma non‐esterified fatty acids (NEFA) and triglycerides (TG). Inhibition of PI3K (wortmannin, 10−7 M) or Akt (triciribine, 10−5 M) reduced relaxation to AICAR only in the control group (p < 0.001). Akt (p‐Akt‐Ser473) and eNOS phosphorylation (p‐eNOS‐Ser1177) were significantly reduced in OP and OR (p < 0.01). Conclusion Endothelial dysfunction caused by HFD is related to a dysfunctional endothelial AMPK–PI3K–Akt–eNOS pathway correlating with the increase of plasma NEFA, TG, and an impaired glucose management.
- 1 October 2014
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 32 (10) , 2082-2091
Development of albuminuria and enhancement of oxidative stress during chronic renin–angiotensin system suppression
Objective: Albuminuria has been recently described in hypertensive patients under chronic renin-angiotensin system (RAS) suppression. We investigated whether this fact could be related to an increase in oxidative stress. Methods: We examined normoalbuminuric and albuminuric patients in stage 2 chronic kidney disease, both with more than 2 years of RAS blockade. The relationship between albuminuria and circulating biomarkers for both oxidative damage, that is carbonyl and malondialdehyde, as well as antioxidant defense, that is reduced glutathione, thiol groups, uric acid, bilirubin, or catalase, and superoxide scavenging activity, was assessed. Results: We found that only patients with albuminuria showed an important increase in carbonyls (P < 0.001) and malondialdehyde (P < 0.05) compared to normoalbuminuric patients. This increase in oxidative damage was also accompanied by a rise in catalase activity (P < 0.05) and low-molecular-weight antioxidants only when they were measured as total antioxidant capacity (P < 0.01). In order to establish the specific oxidative status of each group, new indexes of oxidative damage and antioxidant defense were calculated with all these markers following a mathematical and statistical approach. Although both pro-oxidant and antioxidant indexes were significantly increased in patients with albuminuria, only the oxidative damage index positively correlated with the increase of albumin/creatinine ratio (P = 0.0024). Conclusions: We conclude that albuminuria is accompanied by an amplified oxidative damage in patients in early stages of chronic kidney disease. These results indicate that chronic RAS protection must be directed to avoid development of albuminuria and oxidative damage.
- 1 October 2014
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 32 (10) , 2082-2091
Development of albuminuria and enhancement of oxidative stress during chronic renin–angiotensin system suppression
Objective: Albuminuria has been recently described in hypertensive patients under chronic renin-angiotensin system (RAS) suppression. We investigated whether this fact could be related to an increase in oxidative stress. Methods: We examined normoalbuminuric and albuminuric patients in stage 2 chronic kidney disease, both with more than 2 years of RAS blockade. The relationship between albuminuria and circulating biomarkers for both oxidative damage, that is carbonyl and malondialdehyde, as well as antioxidant defense, that is reduced glutathione, thiol groups, uric acid, bilirubin, or catalase, and superoxide scavenging activity, was assessed. Results: We found that only patients with albuminuria showed an important increase in carbonyls (P < 0.001) and malondialdehyde (P < 0.05) compared to normoalbuminuric patients. This increase in oxidative damage was also accompanied by a rise in catalase activity (P < 0.05) and low-molecular-weight antioxidants only when they were measured as total antioxidant capacity (P < 0.01). In order to establish the specific oxidative status of each group, new indexes of oxidative damage and antioxidant defense were calculated with all these markers following a mathematical and statistical approach. Although both pro-oxidant and antioxidant indexes were significantly increased in patients with albuminuria, only the oxidative damage index positively correlated with the increase of albumin/creatinine ratio (P = 0.0024). Conclusions: We conclude that albuminuria is accompanied by an amplified oxidative damage in patients in early stages of chronic kidney disease. These results indicate that chronic RAS protection must be directed to avoid development of albuminuria and oxidative damage.
- Open Access
- 23 April 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (4) , e95312
Imbalance between Pro and Anti-Oxidant Mechanisms in Perivascular Adipose Tissue Aggravates Long-Term High-Fat Diet-Derived Endothelial Dysfunction
The hypothesis of this study is that long-term high-fat diets (HFD) induce perivascular adipose tissue (PVAT) dysfunction characterized by a redox imbalance, which might contribute to aggravate endothelial dysfunction in obesity. C57BL/6J mice were fed either control or HFD (45% kcal from fat) for 32 weeks. Body weight, lumbar and mesenteric adipose tissue weights were significantly higher in HFD animals compared to controls. The anticontractile effect of PVAT in mesenteric arteries (MA) was lost after 32 week HFD and mesenteric endothelial-dependent relaxation was significantly impaired in presence of PVAT in HFD mice (Emax = 71.0±5.1 vs Emax = 58.5±4.2, p<0.001). The inhibitory effect of L-NAME on Ach-induced relaxation was less intense in the HFD group compared with controls suggesting a reduction of endothelial NO availability. Expression of eNOS and NO bioavailability were reduced in MA and almost undetectable in mesenteric PVAT of the HFD group. Superoxide levels and NOX activity were higher in PVAT of HFD mice. Apocynin only reduced contractile responses to NA in HFD animals. Expression of ec-SOD and total SOD activity were significantly reduced in PVAT of HFD mice. No changes were observed in Mn-SOD, Cu/Zn-SOD or catalase. The ratio [GSSG]/([GSH]+[GSSG]) was 2-fold higher in the mesenteric PVAT from HFD animals compared to controls. We suggest that the imbalance between pro-oxidant (NOX, superoxide anions, hydrogen peroxide) and anti-oxidant (eNOS, NO, ecSOD, GSSG) mechanisms in PVAT after long-term HFD might contribute to the aggravation of endothelial dysfunction.
- 23 April 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (4) , e95312
Open AccessImbalance between Pro and Anti-Oxidant Mechanisms in Perivascular Adipose Tissue Aggravates Long-Term High-Fat Diet-Derived Endothelial Dysfunction
The hypothesis of this study is that long-term high-fat diets (HFD) induce perivascular adipose tissue (PVAT) dysfunction characterized by a redox imbalance, which might contribute to aggravate endothelial dysfunction in obesity. C57BL/6J mice were fed either control or HFD (45% kcal from fat) for 32 weeks. Body weight, lumbar and mesenteric adipose tissue weights were significantly higher in HFD animals compared to controls. The anticontractile effect of PVAT in mesenteric arteries (MA) was lost after 32 week HFD and mesenteric endothelial-dependent relaxation was significantly impaired in presence of PVAT in HFD mice (Emax = 71.0±5.1 vs Emax = 58.5±4.2, p<0.001). The inhibitory effect of L-NAME on Ach-induced relaxation was less intense in the HFD group compared with controls suggesting a reduction of endothelial NO availability. Expression of eNOS and NO bioavailability were reduced in MA and almost undetectable in mesenteric PVAT of the HFD group. Superoxide levels and NOX activity were higher in PVAT of HFD mice. Apocynin only reduced contractile responses to NA in HFD animals. Expression of ec-SOD and total SOD activity were significantly reduced in PVAT of HFD mice. No changes were observed in Mn-SOD, Cu/Zn-SOD or catalase. The ratio [GSSG]/([GSH]+[GSSG]) was 2-fold higher in the mesenteric PVAT from HFD animals compared to controls. We suggest that the imbalance between pro-oxidant (NOX, superoxide anions, hydrogen peroxide) and anti-oxidant (eNOS, NO, ecSOD, GSSG) mechanisms in PVAT after long-term HFD might contribute to the aggravation of endothelial dysfunction.